Tufts CSDD: New Insights on The Clinical Trial Industry
The landscape of clinical trials is undergoing a transformation marked by increasing intricacy and operational challenges. Ken Getz, Executive...
The landscape of clinical trials is undergoing a transformation marked by increasing intricacy and operational challenges. Ken Getz, Executive...
In a pivotal webcast hosted by Medable, a panel of distinguished experts, including Pamela Tenaerts (Chief Scientific Officer at...
Electronic Clinical Outcome Assessments (eCOA) have significantly advanced clinical trials, offering a more accurate and efficient data collection method....
The prevalence of duplicate participants in clinical trials poses significant risks, compromising the integrity of data and the safety...
The FDA’s latest guidance on Decentralized Clinical Trials (DCTs) marks a pivotal shift in the clinical research landscape. This...
In this interview, Michael Torok, Head of Quality Assurance Programs at Roche, delves into the operationalization of RBQM (Risk...
In an era in which the White House Office of Science and Technology Policy emphasizes the need for a...
At the 2023 Medidata NEXT conference, prominent figures like Michelle Hartman from South Broward Research, Adam Kinsey from Merck,...
The Vanguard of Decentralized Clinical Trials: Bayer’s OCEANIC Study The Medidata NEXT conference spotlighted the groundbreaking OCEANIC study by...
In this interview with Gian Carlo (GC) Ochoa, a leading figure in digital twins technology for clinical trials, we...